Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus
Nicholas H. Varvel, Claudia Espinosa‐García, Sarah Hunter-Chang, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 1105-1117
Open Access | Times Cited: 24

Showing 24 citing articles:

Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen, Marwa M. Nagib, Nelufar Yasmen, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 683-701
Open Access | Times Cited: 60
Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies
Wen‐Jun Li, Jinze Wu, Yini Zeng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages
Martina Di Nunzio, Rossella Di Sapia, Diletta Sorrentino, et al.
Epilepsia (2021) Vol. 62, Iss. 8, pp. 1931-1945
Closed Access | Times Cited: 47
Neuroimmunology of status epilepticus
Annamaria Vezzani, Rossella Di Sapia, Valentina Kebede, et al.
Epilepsy & Behavior (2023) Vol. 140, pp. 109095-109095
Closed Access | Times Cited: 18
EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
Madison N. Sluter, R. Hou, Lexiao Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 16, pp. 11816-11836
Open Access | Times Cited: 29
CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy
Rossella Di Sapia, Till S. Zimmer, Valentina Kebede, et al.
Neurobiology of Disease (2021) Vol. 158, pp. 105468-105468
Open Access | Times Cited: 26
Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis
Thota Ganesh
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9313-9324
Open Access | Times Cited: 10
Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders
Chenyao Jiang, Ying Yu, Jiawang Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids
Yan Rong, Linhai Zhang, Ya Chen, et al.
Neurobiology of Disease (2025), pp. 106880-106880
Open Access
Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link
Herlinda Bonilla‐Jaime, Helena Zeleke, Asheebo Rojas, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12531-12531
Open Access | Times Cited: 23
Complementary roles of EP2 and EP4 receptors in malignant glioma
Jian-Ge Qiu, Qianqian Li, Junqi Li, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 20, pp. 2623-2640
Closed Access | Times Cited: 9
Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticus
Carlos Alemán-Ruiz, Wenyi Wang, Raymond Dingledine, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Schwann cell-secreted PGE2 promotes sensory neuron excitability during development
Husniye Kantarci, Pablo D. Elvira, Arun P. Thottumkara, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4690-4712.e30
Closed Access | Times Cited: 3
Distinct Cell-specific Roles of NOX2 and MyD88 in Epileptogenesis
Cayo Almeida, Renan Paschoalino Pongilio, Marília Inês Móvio, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Preclinical development of an EP2 antagonist for post-seizure cognitive deficits
Nicholas H. Varvel, Radhika Amaradhi, Claudia Espinosa‐García, et al.
Neuropharmacology (2022) Vol. 224, pp. 109356-109356
Open Access | Times Cited: 11
Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties
Radhika Amaradhi, Shabber Mohammed, Avijit Banik, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 2, pp. 118-133
Open Access | Times Cited: 9
Phosphoglycerate kinase (PGK) 1 succinylation modulates epileptic seizures and the blood-brain barrier
Yuemei Luo, Juan Yang, Lijia Zhang, et al.
EXPERIMENTAL ANIMALS (2023) Vol. 72, Iss. 4, pp. 475-489
Open Access | Times Cited: 5
Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of Epileptogenesis
Varun Rawat, Clifford L. Eastman, Radhika Amaradhi, et al.
ACS Pharmacology & Translational Science (2022) Vol. 6, Iss. 1, pp. 128-138
Open Access | Times Cited: 7
Neuroinflammation in Epilepsy
Raymond Dingledine, Nicholas H. Varvel, Teresa Ravizza, et al.
Oxford University Press eBooks (2024), pp. 626-632
Closed Access | Times Cited: 1
Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity
Coral M. Stredny, Alexander Rotenberg, Alan Leviton, et al.
Epilepsia Open (2022) Vol. 8, Iss. 1, pp. 221-234
Open Access | Times Cited: 6
Monoclonal Antibodies From Anti-NMDA Receptor Encephalitis Patient as a Tool to Study Autoimmune Seizures
Olga Taraschenko, Howard S. Fox, Ember Eldridge, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 7
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease
Avijit Banik, Radhika Amaradhi, Daniel Lee, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features
Shan Qiao, Quanye Sun, Haiyun Li, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access
Myeloid EP2 Receptors in Status Epilepticus—Peripheral But Not Negligible
Christina Groß
Epiliepsy currents/Epilepsy currents (2021) Vol. 21, Iss. 3, pp. 194-196
Open Access
Page 1

Scroll to top